Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 29;9(11):3491.
doi: 10.3390/jcm9113491.

Frailty Is a Better Predictor than Age of Mortality and Perioperative Complications after Surgery for Degenerative Cervical Myelopathy: An Analysis of 41,369 Patients from the NSQIP Database 2010-2018

Affiliations

Frailty Is a Better Predictor than Age of Mortality and Perioperative Complications after Surgery for Degenerative Cervical Myelopathy: An Analysis of 41,369 Patients from the NSQIP Database 2010-2018

Jamie R F Wilson et al. J Clin Med. .

Abstract

Background: The ability of frailty compared to age alone to predict adverse events in the surgical management of Degenerative Cervical Myelopathy (DCM) has not been defined in the literature.

Methods: 41,369 patients with a diagnosis of DCM undergoing surgery were collected from the National Surgical Quality Improvement Program (NSQIP) Database 2010-2018. Univariate analysis for each measure of frailty (modified frailty index 11- and 5-point; MFI-11, MFI-5), modified Charlson Co-morbidity index and ASA grade) were calculated for the following outcomes: mortality, major complication, unplanned reoperation, unplanned readmission, length of hospital stay, and discharge to a non-home destination. Multivariable modeling of age and frailty with a base model was performed to define the discriminative ability of each measure.

Results: Age and frailty have a significant effect on all outcomes, but the MFI-5 has the largest effect size. Increasing frailty correlated significantly with the risk of perioperative adverse events, longer hospital stay, and risk of a non-home discharge destination. Multivariable modeling incorporating MFI-5 with age and the base model had a robust predictive value (0.85). MFI-5 had a high categorical assessment correlation with a MFI-11 of 0.988 (p < 0.001).

Conclusions and relevance: Measures of frailty have a greater effect size and a higher discriminative value to predict adverse events than age alone. MFI-5 categorical assessment is essentially equivalent to the MFI-11 score for DCM patients. A multivariable model using MFI-5 provides an accurate predictive tool that has important clinical applications.

Keywords: age; complications; degenerative cervical myelopathy; frailty; mortality.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Predictive margins of the final multivariable model for each frailty level stratified per decade of age, for each outcome studied. Decades of age were removed if co-linearity was present. 95% CI, 95% Confidence Interval.

Similar articles

Cited by

References

    1. Karadimas S.K., Erwin W.M., Ely C.G., Dettori J.R., Fehlings M.G. Pathophysiology and Natural History of Cervical Spondylotic Myelopathy. Spine. 2013;38:S21–S36. doi: 10.1097/BRS.0b013e3182a7f2c3. - DOI - PubMed
    1. Nouri A., Tetreault L., Singh A., Karadimas S.K., Fehlings M.G. Degenerative Cervical Myelopathy. Spine. 2015;40:E675–E693. doi: 10.1097/BRS.0000000000000913. - DOI - PubMed
    1. Wilson J.R.F., Badhiwala J., Jiang F., Wilson J.R., Kopjar B., Vaccaro A.R., Fehlings M.G. The Impact of Older Age on Functional Recovery and Quality of Life Outcomes after Surgical Decompression for Degenerative Cervical Myelopathy: Results from an Ambispective, Propensity-Matched Analysis from the CSM-NA and CSM-I International, Multi-Center Studies. J. Clin. Med. 2019;8:1708. doi: 10.3390/jcm8101708. - DOI - PMC - PubMed
    1. Wilson J.R., Badhiwala J.H., Moghaddamjou A., Martin A.R., Fehlings M.G. Degenerative Cervical Myelopathy; A Review of the Latest Advances and Future Directions in Management. Neurospine. 2019;16:494–505. doi: 10.14245/ns.1938314.157. - DOI - PMC - PubMed
    1. Institute of Medicine Initial National Priorities for Comparative Effectiveness Research . Initial National Priorities for Comparative Effectiveness Research. The National Academies Press; Washington, DC, USA: 2009.

LinkOut - more resources